Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer Diagnoses Still Lagging; Cancer and Family Health; New Type of Lung Cancer

2.

Glioblastoma cells can 'unstick' from their neighbors to become more deadly

3.

Getting More Done With Less Blood.

4.

Patients with resected head and neck cancers may benefit clinically from an investigational personalized vaccine.

5.

Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot